A laboratory assessment of ciprofloxacin and comparable antimicrobial agents (Q54471103)

30 May 2018

title

A laboratory assessment of ciprofloxacin and comparable antimicrobial agents (English)

1 reference

4 September 2023

1 reference

4 September 2023

author name string

L. Shrire

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237900

4 September 2023

J. Saunders

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237900

4 September 2023

R. Traynor

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237900

4 September 2023

H. J. Koornhof

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6237900

4 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6237900

4 September 2023

publication date

1 August 1984

1 reference

30 May 2018

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF01977488.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01977488/fulltext.html

4 September 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF01977488

4 September 2023

1 reference

European journal of clinical microbiology

4 September 2023

published in

1 reference

30 May 2018

volume

3

1 reference

30 May 2018

issue

4

1 reference

30 May 2018

page(s)

328-332

1 reference

30 May 2018

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01977488

Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01977488

In vitro and in vivo antibacterial activity of AT-2266.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01977488

Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01977488

Norfloxacin penetration into subcutaneous tissue cage fluid in rabbits and efficacy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01977488

Comparative in vitro activity of norfloxacin against urinary tract pathogens

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6237900

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6237900

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The comparative activity of norfloxacin with other antimicrobial agents against Gram-positive and Gram-negative bacteria.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6237900

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF01977488

1 reference

30 May 2018

1 reference

30 May 2018